🌙 The Q1 Closer Nobody Expected

📊 Closing Bell — 6:00 PM ET

🕊️ Ceasefire Rally: Real or Head Fake?

The catalyst was exactly what this morning's brief flagged: Trump told aides he's willing to wind down military operations against Iran — even if the Strait of Hormuz remains partially blocked. The WSJ report hit pre-market, sending futures soaring. Then around 12:30 PM, additional White House reports of a diplomatic shift on Hormuz security triggered a second buying wave that pushed the Dow past +1,000.

The advance-decline ratio ran 5-to-1 positive on the NYSE. The S&P 500 formed a textbook bullish engulfing candle off its 200-day moving average. Breadth was broad — this wasn't just mega-cap tech dragging the index higher. Small-caps in the Russell 2000 rallied hard, signaling genuine risk appetite returning.

The caveat: Volume faded into the close. The most aggressive short covering happened by mid-afternoon, and the final hour was more drift than conviction. Gulf states reportedly want the war to continue until Iran is neutralized as a regional threat. "Willing to wind down" and "war is over" are very different sentences.

💻 Tech Leads the Charge

Nvidia surged 5.6% and dropped a $2 billion bomb of its own — a strategic stake in Marvell Technology (MRVL +10%), bringing Marvell into the NVLink Fusion ecosystem for custom AI infrastructure. Goldman reiterated a buy, citing Nvidia's 18-year healthcare AI play.

Alphabet jumped 5% after launching Veo 3.1 Lite — a cheaper AI video model at half the price of its "Fast" tier, perfectly timed to fill the vacuum left by OpenAI killing Sora. Price cuts across the Veo lineup signal Google is playing for market share while competitors regroup.

Microsoft gained 3.1% as Wells Fargo reiterated overweight ahead of earnings, projecting sustained high-30s% Azure revenue growth through FY28.

💊 Novo Nordisk Reinvents the Pill Bottle

NVO rose 4.1% after launching subscription pricing for Wegovy — a direct-to-consumer model via telehealth platforms like WeightWatchers (WW +4.2%) that saves patients up to $600/year on the pill and $1,200 on the injectable. Eli Lilly (LLY +3.7%) got a sympathy bid as both GLP-1 giants experiment with cash-pay models. Distribution is becoming the battleground, not just the molecule.

📋 Quick Hits

• Q1 final score: Nasdaq -7%, S&P 500 -4.6%, Dow -3.6%. Energy up ~20%. Brent posted a 55% monthly gain — the largest in its 38-year history. Quite the quarter.
• Consumer Confidence edged up to 91.8, slightly beating expectations despite $4/gallon gasoline and war anxiety.
• Nvidia → Marvell: The $2B stake makes MRVL a formal part of the NVLink AI ecosystem. Custom XPUs meet rack-scale compute. Chip bulls needed this.
• BridgeBio (BBIO +7%) reported long-term mortality advantage for Attruby over Pfizer's Vyndamax — a potential game-changer in cardiac treatment.
• Aehr Test Systems (AEHR +23%) landed a major undisclosed customer in AI data center silicon photonics. Earnings April 7.
• Oil retreated: Brent fell ~2% to $105 as ceasefire hopes took the edge off, but gasoline remains above $4/gallon nationally.

🧠 What to Watch Tomorrow

• The gap test. Today's gap-up created a "support gap" on the S&P 500 chart. If April 1 holds above 6,343 (yesterday's close), bulls are in control. If it fills the gap, today was a head fake.
• Iran headlines. Gulf states pushing for continued operations vs. Trump's wind-down signals. The next 48 hours of diplomatic noise will set the tone for the week.
• Jobs report positioning. NFP drops Friday morning — but markets are closed for Good Friday. That means Wednesday and Thursday are the only sessions to position. Expect elevated volatility mid-week.
• Crypto disconnect. BTC barely moved on a day when equities surged 3-4%. Either crypto is leading or lagging — and the answer matters for April.